Tempus AI Inc - TEM Real Price to Acquire Entire Company

Brandmark of Tempus Labs (TEM)

The market dynamics of Tempus AI, Inc (TEM) on the GURU.Markets platform demonstrate an enterprise value of 12867.55. Tempus AI, Inc (TEM) implements precision medicine by partnering with clinics and pharmaceutical behemoths to develop personalized cancer treatments via AI. Monetization relies on the sale of unique arrays of digitized medical data, while testing continuity is ensured by a streamlined biomaterial collection system and the diversification of consumables supplies.

TEM (Tempus AI, Inc.) Total Company Value history from 11/23/2025 to 10/27/2026

Metric breakdowns and analytics for Tempus AI Inc (TEM)

- price and consensus price forecast:
Market Price Tempus AI|TEM - Price Target Chart
- market capitalization data:
Market Valuation Tempus|TEM - Enterprise Value
- book capitalization data:
Equity per Share Tempus|TEM - Company Book Value|Capitalization to Book Value Ratio tempus.com|TEM - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Tempus AI, Inc|TEM - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Tempus Labs|TEM - Company Aggregate Debts|Debts to Book Value Tempus
Fundamental valuation:tempus.com (TEM)
Mass-produced product of Tempus AI, Inc.

Tempus AI, Inc (TEM) leverages a unique molecular database and inelastic demand for oncology diagnostics to maintain significant pricing power, which directly impacts the company's enterprise value. This indicator aggregates market capitalization and net debt to determine the actual cost of acquiring the asset; a substantial deviation of current values from historical averages signals overvaluation and risks of a correction.

Competitor analysis for Tempus AI, Inc

Qiagen NV - Total Enterprise Value|IONS: Total Company Value|RGEN - Real Price to Acquire Entire Company|Enterprise Value Avidity Biosciences|CRSP (crisprtx.com) - Business Value|Total Company Value GeneDx (WGS)|Business Value Ultragenyx Pharmaceutical Inc.|Enterprise Value BEAM|Enterprise Value Sarepta Corp SRPT|Real Price to Acquire Entire Company Twist Bioscience (TWST)|Aggregate Business Value 10xgenomics.com TXG|NTLA (Intellia Therapeutics, Inc.) - Enterprise Value|STOK: Total Enterprise Value|BLFS (BioLife Corp) - Total Company Value|WVE (Wave Pharma) - Real Price to Acquire Entire Company|Total Company Value Maze Therapeutics Inc MAZE|Full Business Value sionnatx.com (SION)|Real Price to Acquire Entire Company PRME|Enterprise Value TSHA (Taysha Gene Therapies Inc)|Total Company Value QURE|MGTX - Company Buyout Price|Real Price to Acquire Entire Company REGENXBIO Inc. (RGNX)|SLDB - Value Adjusted for Debt and Cash|OCGN: Enterprise Value|Pacific Biosciences of California, Inc. (PACB) - Enterprise Value|BNTC: Enterprise Value|Company Buyout Price Design Corp (DSGN)|Rocket Pharmaceuticals (RCKT) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash 4dmoleculartherapeutics.com (FDMT)|Enterprise Value LXEO|Korro Bio Inc. - Company Buyout Price|Editas (EDIT) - Total Company Value|SLN - Business Value|PRQR (proqr.com) - Enterprise Value|Real Price to Acquire Entire Company Codexis|Sangamo Therapeutics, Inc. (SGMO) - Real Price to Acquire Entire Company|Aggregate Business Value Nautilus Biotechnology Inc|Metagenomi, Inc - Enterprise Value|Total Enterprise Value DTIL (precisionbiosciences.com)|Generation Bio - Total Company Value|Real Price to Acquire Entire Company boundlessbio.com BOLD|Exicure Corp (XCUR) - Enterprise Value|IMNN: Business Value|Total Company Value phiopharma.com|Mustang Bio (MBIO) - Business Value|RNAZ (TransCode Therapeutics Inc.) - Enterprise Value|Enterprise Value Bionano (BNGO)|Real Price to Acquire Entire Company Applied DNA Sciences, Inc.|Aggregate Business Value bluebird bio Inc. (BLUE)|IPA: Enterprise Value|Omega Therapeutics Corp - Total Enterprise Value|OMIC: Total Company Value|RGLS: Real Price to Acquire Entire Company|Total Company Value Syros Pharmaceuticals, Inc. (SYRS)|Full Business Value Telesis Bio Inc.|TCON (TRACON) - Real Price to Acquire Entire Company|Enterprise Value UBX